Palo Alto Investors LP Portfolio Holdings
Palo Alto Investors LP
- $727 Million
- Q3 2024
Palo Alto Investors LP has filed its 13F form on November 14, 2024 for Q3 2024 where it was disclosed a total value porftolio of $727 Million distributed in 45 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Insmed Inc with a value of $142M, Amicus Therapeutics, Inc. with a value of $87M, Biomarin Pharmaceutical Inc with a value of $76.6M, United Therapeutics Corp with a value of $65.7M, and Biogen Inc. with a value of $44.4M.
Examining the 13F form we can see an decrease of $62.9M in the current position value, from $790M to 727M.
Palo Alto Investors LP is based out at Palo Alto, CA
Below you can find more details about Palo Alto Investors LP portfolio as well as his latest detailed transactions.